Items tagged with HIV coinfection
Isoniazid preventive treatment reduces the risk of death by 37% in people living with HIV (post)
A six-month course of isoniazid preventive treatment (IPT) at the beginning of the Temprano trial in Ivory Coast reduced the risk of death by 37% over a mean follow-up period of 4.5 years, Anani Badje reported at the 2017 Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle on Wednesday.
HIV and TB co-infection: treat early (post)
Tuberculosis (TB) and HIV are 2 of the deadliest diseases worldwide, with TB recently reaching the top of the list in 2014. HIV increases the risk of contracting TB, whereas TB slows CD4 count recovery and hastens HIV progression to AIDS. Approximately 1/3 of the 1.5 million people who died of TB in 2014 were also infected with HIV.
HIV co-infection influences natural selection on M. tuberculosis (post)
Tuberculosis (TB) remains a major global health problem, with 10 million cases and 2 million deaths per year, according to the World Health Organization. The only available vaccine is effective in children but its effect wanes in older children and adults.
UNAIDS warns that countries will miss the 2020 target of reducing HIV-associated TB deaths by 75% unless urgent action is taken (post)
GENEVA, 24 March 2017—On World Tuberculosis Day, 24 March, UNAIDS is urging countries to do much more to reduce the number of tuberculosis (TB) deaths among people living with HIV. TB is the most common cause of hospital admission and death among people living with HIV. In 2015, 1.1 million people died from an AIDS-related illness—around 400 000 of whom died from TB, including 40 000 children.
Health system navigators didn't improve ART initiation or TB treatment completion rates among people newly diagnosed with HIV in Durban (post)
An intervention using health system navigators, phone support and text message reminders did not improve rates of people living with HIV initiating antiretroviral therapy (ART) or completing treatment for tuberculosis (TB), investigators report in the Journal of Acquired Immune Deficiency Syndromes.
Progress and prospects for the control of HIV and TB in South Africa: a dynamical modelling study (post)
Summary
PEPFAR approves 2017 budget to support South Africa’s fight against HIV/AIDS and TB (post)
On April 25, U.S. Global AIDS Coordinator and Special Representative for Global Health Diplomacy, Ambassador Deborah Birx, approved PEPFAR’s $483 million Country Operational Plan 2017 (COP2017) budget for South Africa, an increase over 2016. The COP2017 budget will support South Africa’s HIV/AIDS and tuberculosis (TB) programs through September 2018. The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) is the U.S. government’s initiative to help save the lives of those infected with and affected by HIV/AIDS around the world. Since 2004, PEPFAR has invested over $5.6 billion in South Africa’s response to prevent and treat HIV/AIDS and TB. This investment has saved the lives of millions of South Africans.
TB/HIV outreach finding patients in remote South Africa (post)
A novel tuberculosis and HIV case-finding method effectively detected people with both diseases in a remote area of South Africa, according to researchers.
Zimbabwe’s Vice President and Minister of Health sign Barcelona Declaration and commit to ending TB and HIV-TB (post)
On 28 April 2017, Zimbabwe’s Vice President Phelekezela Mphoko and the Minister of Health and Child Care Dr David Parirenyatwa signed the Barcelona Declaration on tuberculosis (TB) and the localised Bulawayo Declaration on HIV-TB to demonstrate the government’s commitment to ending the two diseases by 2030.
Page 21 of 52 · Total posts: 0
←First 20 21 22 Last→